Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 EUR | 0.00% | 0.00% | +31.19% |
Mar. 20 | Geneuro SA Announces Appointments of Board of Directors | CI |
Feb. 02 | GeNeuro: share price falls after private placement | CF |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 50.18 | 53.94 | 57.33 | 78.83 | 37.3 | 42.32 | 42.32 | - |
Enterprise Value (EV) 1 | 41.41 | 51.36 | 50.49 | 74.25 | 31.71 | 55.32 | 50.22 | 77.22 |
P/E ratio | -6.04 x | -5.69 x | -6.22 x | -11.1 x | -2.94 x | -3.33 x | 47.7 x | -1.64 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 6.72 x | - | - | - | - | - | 1.5 x | - |
EV / Revenue | 5.55 x | - | - | - | - | - | 1.78 x | - |
EV / EBITDA | -5.16 x | - | - | - | - | -4.9 x | 33.5 x | -2.87 x |
EV / FCF | -2.36 x | -5.17 x | - | - | - | -4.85 x | - | -2.86 x |
FCF Yield | -42.4% | -19.4% | - | - | - | -20.6% | - | -35% |
Price to Book | 9.08 x | -10.3 x | 10.4 x | - | - | -3.76 x | -11.9 x | -1.44 x |
Nbr of stocks (in thousands) | 14,589 | 14,579 | 20,476 | 22,204 | 24,868 | 29,596 | 29,596 | - |
Reference price 2 | 3.440 | 3.700 | 2.800 | 3.550 | 1.500 | 1.430 | 1.430 | 1.430 |
Announcement Date | 4/1/19 | 4/7/20 | 4/6/21 | 4/4/22 | 4/5/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 7.463 | - | - | - | - | - | 28.2 | - |
EBITDA 1 | -8.02 | - | - | - | - | -11.3 | 1.5 | -26.9 |
EBIT 1 | -8.089 | -8.99 | -7.459 | -6.366 | -11.23 | -11.3 | 1.5 | -26.9 |
Operating Margin | -108.38% | - | - | - | - | - | 5.32% | - |
Earnings before Tax (EBT) | -8.328 | -9.461 | - | - | - | - | - | - |
Net income 1 | -8.328 | -9.461 | -8.962 | -6.818 | -12.2 | -11.3 | 1.1 | -26.9 |
Net margin | -111.59% | - | - | - | - | - | 3.9% | - |
EPS 2 | -0.5700 | -0.6500 | -0.4500 | -0.3200 | -0.5100 | -0.4300 | 0.0300 | -0.8700 |
Free Cash Flow 1 | -17.56 | -9.943 | - | - | - | -11.4 | - | -27 |
FCF margin | -235.29% | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 4/1/19 | 4/7/20 | 4/6/21 | 4/4/22 | 4/5/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 13 | 7.9 | 34.9 |
Net Cash position 1 | 8.78 | 2.58 | 6.84 | 4.57 | 5.59 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | -1.15 x | 5.267 x | -1.297 x |
Free Cash Flow 1 | -17.6 | -9.94 | - | - | - | -11.4 | - | -27 |
ROE (net income / shareholders' equity) | -89.5% | - | - | -132% | -387% | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | 0.3800 | -0.3600 | 0.2700 | - | - | -0.3800 | -0.1200 | -0.9900 |
Cash Flow per Share 2 | -1.200 | -0.6800 | -0.3600 | -0.3200 | -0.5500 | -0.4500 | 0.0400 | -0.9000 |
Capex 1 | 0.03 | 0.05 | - | - | - | 0.1 | 0.1 | 0.1 |
Capex / Sales | 0.41% | - | - | - | - | - | 0.35% | - |
Announcement Date | 4/1/19 | 4/7/20 | 4/6/21 | 4/4/22 | 4/5/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+31.19% | 45.18M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GNRO Stock
- Financials GeNeuro SA